FDA Fires Vinay Prasad, Biotech Left Swiping Left
In this week's episode of 'The Readout LOUD,' STAT's sharp biotech reporters dissect the drama behind Vinay Prasad's ouster from the FDA, leaving the biotech world wondering if this is a plot twist or just another episode of regulatory Game of Thrones. As the show bluntly puts it, they 'parse what Vinay Prasad's ouster means for biotech and the FDA,' because nothing says biotech thrill like politics and power moves thicker than a monoclonal antibody cocktail.
Share the Story
Vinay Prasad gets the boot and the biotech world collectively checks if FDA drama is now their new soap opera. Spoiler: No one’s safe, and placebo effects are looking more like real ones.
Prasad’s exit proves biotech can’t have nice things, especially when FDA offices feel more like reality TV voting circles. Who’s next—Frank Underwood with a lab coat?
FDA just threw Vinay Prasad out like last season’s leftover pipettes. Meanwhile, scientist emojis everywhere are loading their CRISPR guns for clout.
Source: Statnews | Published: 7/31/2025 | Author: Elaine Chen, Adam Feuerstein, and Matthew Herper
More Articles in Science
America Adds 50,000 Jobs, But Those 70,000 Stayed Home for Holidays
USS Gerald R. Ford Saves Day By 'Apprehending' Another Wobbly Tanker
Chinese Crackdowns Cut US Fentanyl Supply, Trump Declares Pills Weapons of Mass Destruction
SpaceX’s Starlink Satellite Has Midlife Crisis, Explodes Dramatically
Scientists Officially Declare Adulthood Brain Is Just Long Teenage Brain Saga
Ozone Hole Slowly Shrinks, Planet Pretends To Care Until Next Summer
Leonids Showers: Stargaze Naps & Smoke Trails, Not Meteorites
Bezos' New Glenn: Rocket Spat Out Mars, Slurped Booster Back
